drugset / Trial / NCT00588835
Pharmacokinetic Study on the Addition of Aprepitant to Cisplatin - Etoposide Treatment in Lung Cancer Patients
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to determine whether aprepitant can be used in the Cisplatin - Etoposide chemotherapeutic regimen.
Timeline
- Start
- 2008-03
- Primary completion
- 2010-01
- Completion
- 2010-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aprepitant | Other / unclassified | 80 mg | Oral |
| Comparator | Dexamethasone | Small molecule | — | — |
| Comparator | Ondansetron | Other / unclassified | — | — |